Effects of Moderate/Severe Traumatic Brain Injury in the Subacute or Chronic Phase on Locomotor Strategies Involved in Navigation in Complex Virtual Environments
NCT ID: NCT07230002
Last Updated: 2025-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2025-11-30
2026-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combinated Cues and Virtual Spatial Navigation
NCT03534128
Immersive Virtual Reality in Cognitive Rehabilitation of Patients With Post-Stroke Cognitive Impairment
NCT07125170
Personalized Cognitive Integrated Motor Training Using Virtual Reality to Improve Gait and Balance
NCT06473987
Tolerance of an Immersive Virtual Reality Task Evaluating the Spatial Memory of Elderly Subjects
NCT05996250
VR Cognitive Rehabiliation for Pediatric TBI
NCT04526639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single group
Patients as well as healthy participants will be asked to perform several exercises under virtual reality conditions. Questionnaires and scales will also be completed by the participants.
Locomotion in a virtual reality setting
Patients and participants will be asked to perform several walking/locomotion tasks in a virtual evironment setting. The setting in question is a concert in a parc. The participants will have to walk towards the stage whilst avoiding bumping into "virtual people". A total of 5 different tasks (walking in a straight line, walking between people etc) will be completed for each participant. Different variables will then be recorded and extracted such as walking speed, interpersonnal distances, eye fixation times.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Locomotion in a virtual reality setting
Patients and participants will be asked to perform several walking/locomotion tasks in a virtual evironment setting. The setting in question is a concert in a parc. The participants will have to walk towards the stage whilst avoiding bumping into "virtual people". A total of 5 different tasks (walking in a straight line, walking between people etc) will be completed for each participant. Different variables will then be recorded and extracted such as walking speed, interpersonnal distances, eye fixation times.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male/female
* Having suffered a first non-penetrating head injury
* Moderate to severe severity with initial Glasgow Coma Scale score 5\<GCS\<13
* In the subacute or chronic phase (≥ 3 months at the date of the experiment, relative to the date of the injury)
* Able to walk (10WMT speed ≥ 0.8 m/s, able to walk at least 20 m without technical or human assistance, PM ≥ 300 m)
* Able to maintain dynamic balance while standing (TUG\<16s)
* Able to answer simple questionnaires, according to the investigator's judgment
* Having given their free, informed, expressed (written) consent
* Registered with a social security system
* Individuals under legal protection measures such as guardianship may be eligible
* 18 ≤ Age ≤ 55 years old
* Male/female
* Able to walk (≥ 0.8 m/s, able to walk at least 20 m without technical or human assistance, PM ≥ 300 m)
* Able to answer simple questionnaires, according to the investigator's judgment
* Having given free, informed, expressed (written) consent
* Registered with a social security system
Exclusion Criteria
* Severe patho-psychiatric care underway, which may impact the conduct of the protocol, at the investigator's discretion
* Presence of neurological signs suggestive of a neurodegenerative disease responsible for gait disturbance (Parkinson's syndrome, Alzheimer's disease, etc.)
* Individuals with musculoskeletal disorders that impact their locomotor abilities
* Presence of uncontrolled epilepsy at the time of inclusion
* Presence of visual impairments that make experimentation impossible, at the discretion of the investigator
* Pregnant, parturient, or breastfeeding women
* Participants in another ongoing research protocol involving human subjects
* Presence of fatigue, trauma, or a condition affecting mobility, posture, balance, or walking
* Persons deprived of their liberty by a judicial or administrative decision
* Persons deprived of their liberty by judicial or administrative decision
* Persons under legal protection (guardianship, curatorship, judicial protection) or unable to express their consent
* Persons undergoing severe psychiatric treatment or admitted to a health or social care facility for purposes other than research.
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pôle Saint Hélier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation Saint Helier
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00679-40
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.